Clinical Trials on Myeloma, Multiple
Total 12410 results
-
University of NebraskaM.D. Anderson Cancer CenterTerminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaMultiple Myeloma | Refractory Multiple Myeloma | Relapsed/Refractory Multiple MyelomaUnited States
-
Oncopeptides ABTerminatedRelapsed Multiple Myeloma | Relapsed-Refractory Multiple MyelomaSerbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
-
Chongqing Precision Biotech Co., LtdEnrolling by invitationMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryChina
-
Poitiers University HospitalSanofi; Celgene; Amgen; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryFrance
-
Gadeta B.V.Active, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Cogent Biosciences, Inc.Seagen Inc.TerminatedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
CASI Pharmaceuticals, Inc.CompletedRelapsed Multiple Myeloma | Plateau Phase Multiple MyelomaUnited States
-
PfizerActive, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Myeloma | Relapsed Multiple Myeloma | Elranatamab | PF-06863135 | BCMA | Bispecific | Bispecific Antibody | BCMA-CD3 Bispecific | MagnetisMM-8China
-
National Cancer Institute (NCI)CompletedMyeloma-Multiple | Myeloma, Plasma-CellUnited States
-
XuYanRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryChina
-
Dong-A University HospitalAmgenNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Dana-Farber Cancer InstituteNational Institutes of Health (NIH); Genus Oncology, LLCWithdrawnMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Not yet recruitingRefractory Multiple Myeloma | Recurrent Multiple Myeloma
-
Elvira UmyarovaSanofiRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of WashingtonGenzyme, a Sanofi CompanyRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Peter MacCallum Cancer Centre, AustraliaUnknownMultiple Myeloma | Myelodysplastic Syndrome | Acute Myeloid LeukaemiaAustralia
-
Jonsson Comprehensive Cancer CenterWithdrawnRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian HealthTerminatedMyeloma-Multiple | Myeloma, Plasma-Cell | MyelomatosisUnited States
-
Abdullah KhanRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Mayo ClinicRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Fortis Therapeutics, Inc.CompletedMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma With Failed RemissionUnited States
-
Millennium Pharmaceuticals, Inc.CompletedWaldenstrom Macroglobulinemia | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.UnknownMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma ProgressionChina
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingRefractory Multiple Myeloma | Multiple Myeloma in Relapse | Plasmacytoid; LymphomaChina
-
National Cancer Institute (NCI)CompletedAnemia | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingMultiple Myeloma | Relapsed and/or Refractory Multiple Myeloma (RRMM) | Newly Diagnosed Multiple Myeloma (NDMM)United States
-
National Cancer Institute (NCI)RecruitingPlasmacytoma | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Peng LiuShanghai East Hospital; Hrain BiotechnologyUnknownMultiple Myeloma in Relapse | Multiple Myeloma ProgressionChina
-
Memorial Sloan Kettering Cancer CenterHealthTree FoundationRecruitingMultiple Myeloma, SmolderingUnited States
-
Regeneron PharmaceuticalsRecruiting
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.TerminatedHigh Risk Smoldering Multiple MyelomaUnited States
-
University of ArkansasMillennium Pharmaceuticals, Inc.CompletedAsymptomatic Multiple MyelomaUnited States
-
AGC Biologics S.p.A.Horizon 2020 - European CommissionTerminatedAcute Myeloid Leukemia | Multiple MyelomaItaly, Czechia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma-Light Chain OnlyUnited States
-
University of Illinois at ChicagoCompletedMultiple Myeloma, Relapsed | Multiple Myeloma, Refractory to Standard TreatmentUnited States
-
Janssen Research & Development, LLCCompletedHigh-risk Smoldering Multiple MyelomaUnited States, United Kingdom, Belgium, Germany, France, Spain, Korea, Republic of, Australia, Israel, Greece, Sweden
-
Shanghai Theorion Pharmaceutical Co Ltd.Shanghai Institute of Materia Medica, Chinese Academy of SciencesUnknownRefractory Multiple Myeloma | Recurrent Multiple MyelomaChina
-
OncotherapeuticsWithdrawnStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
Nantes University HospitalNot yet recruiting
-
K36 Therapeutics, Inc.RecruitingMultiple Myeloma | Myeloma | Myeloma MultipleUnited States, France, Spain, Canada
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
Azienda Ospedaliera Universitaria SeneseJanssen-Cilag S.p.A.RecruitingMyeloma MultipleItaly
-
University Hospital, BordeauxRecruiting
-
Ivan S MoiseevTerminated
-
Chong Kun Dang PharmaceuticalUnknownMyeloma, MultipleKorea, Republic of